Advertisement
Retrospective findings from an executive health program spur interest in broader studies
Inflammation found more predictive of events than LDL-C in pooled analysis of RCTs
Findings bolster the oral drug as an option for primary and secondary prevention
Human and animal studies show a rise in platelet reactivity, thrombosis and cardiac events
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic leads pioneering assessment of the AI model for health information purposes
ACC committee underscores need to properly weigh benefits in risk-benefit calculations
Two major trials promise key progress against the last unaddressed major risk factor
Effect on gut microbiome emerges as another benefit of statin therapy
Randomized controlled study undercuts unsubstantiated ‘heart health’ claims
Increased risk is partly mediated by microbiota-derived metabolites of L-carnitine, choline
Advertisement
Advertisement